{"id":"W4416930849","doi":"10.1055/s-0045-1812988","title":"Safety and Efficacy in Pediatric Patients with Relapsed/Refractory Classic Hodgkin Lymphoma enrolled on an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin (E4412)","year":2025,"lang":"","type":"article","venue":"Klinische Pädiatrie","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Hodgkin lymphoma; Nivolumab; Lymphoma; Phases of clinical research; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001698639,0.0007776305,0.00269088,0.0008745807,0.000485281,0.00005035377,0.0003717592,0.0003306917,0.00003882786],"category_scores_gemma":[0.001184669,0.0005183268,0.0003275929,0.00140473,0.0006198018,0.0002289724,0.0004546113,0.0004312719,0.000002141795],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003104474,"about_ca_system_score_gemma":0.0008961894,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002864717,"about_ca_topic_score_gemma":0.0002111149,"domain_scores_codex":[0.9928706,0.002231777,0.002411956,0.001083238,0.0008638134,0.0005386443],"domain_scores_gemma":[0.9933075,0.003442631,0.001436606,0.001165359,0.0003780963,0.0002698244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2253997,0.2343665,0.4711432,0.0003259597,0.001329533,0.0000216195,0.005929216,0.00002532542,0.000007681621,0.000499331,0.00008216447,0.06086978],"study_design_scores_gemma":[0.5523507,0.01607115,0.4264237,0.0003834861,0.00333597,9.545153e-7,0.000699324,0.0003397528,0.00007141923,0.0000315215,0.00005302196,0.0002389677],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868304,0.004071412,0.00001131574,0.0003962652,0.0006122156,0.007335738,0.0001309918,0.00002713591,0.0005845119],"genre_scores_gemma":[0.9966108,0.002639979,0.00004361199,0.00009189196,0.00007662019,0.0002248303,0.00007145809,0.00005756288,0.0001832602],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3269511,"threshold_uncertainty_score":0.9997268,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006988153577421633,"score_gpt":0.2628725201907544,"score_spread":0.2558843666133328,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}